This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Alharbi, E., Skeva, R., Juty, N., Jay, C. & Goble, C. Data Intell. 3, 507–527 (2021).
Harrow, I., Balakrishnan, R., McGinty, H. K., Plasterer, T. & Romacker, M. Drug Discov. Today 27, 1441–1447 (2022).
van Vlijmen, H. et al. Data Intell. 2, 276–284 (2020).
Acknowledgements
We thank A. X. Yee for writing and editing assistance.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
K.H. is Senior Director, Informatics and Technology, at MOMA Therapeutics. S.H. is Head of Genedata Screener Business Unit, at Genedata, AG.
Rights and permissions
About this article
Cite this article
Hardy, K., Heyse, S. FAIR data policies can benefit biotech startups. Nat Biotechnol 41, 1060–1061 (2023). https://doi.org/10.1038/s41587-023-01892-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-023-01892-8